English
  • English

CONTACT

Contact us

If you have any questions or comments about this website, please contact our Value@Heart Team: info[at]valueatheart(dot)com.

Talk to us

Talk to Abbott Vascular

At Abbott, we are advancing the treatment of vascular diseases through breakthrough medical technologies, allowing people to return to health and get on with their lives. Abbott focuses on improving integrated diagnostic, treatment and aftercare options for coronary artery disease. And, we’re working on next-generation breakthroughs that unlock the potential to improve the way doctors take care of people with cardiovascular diseases.

Want to learn more about our coronary artery solutions and our commitment to value-based procurement?

Contact us

Talk to us
Talk to us
Register now
Register now

You Are About To Leave www.valueatheart.com

You are now leaving www.valueatheart.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

Disclaimer

For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labelling for prescriptive information and operating instructions.

This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.